Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Applications
ELISA
Western Blot
3D Cell Culture
Spatial Biology
PCR
Quantitative PCR
Digital PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
Application Notes
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Antibodies
Antibodies
PE anti-human CD4
PE anti-human CD4 from BioLegend
(1)
Write a review
Citations:
(92)
Supplier Page
Supplier Page from
BioLegend for
PE anti-human CD4
BioLegend's
PE anti-human CD4
is a Mouse monoclonal antibody. It reacts with Homo Sapiens, and Human. This antibody has been shown to work in applications such as: Flow Cytometry.
Description
PE anti-human CD4 [RPA-T4]
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
PE anti-human CD4
Company
BioLegend
Price
$325.00
Supplier Page
View Company Product Page
Catalog Number
300539
Quantity
500T
Applications
FC
Conjugate/Tag
PE
Format
µg size: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Reactivity
Human
Isotype
Mouse IgG1, κ
Clone
RPA-T4
Host
Mouse
Antibody Type
Primary
NCBI Full Gene Name
CD4 molecule
NCBI Gene Aliases
CD4mut, IMD79, Leu-3, OKT4D, T4
Clonality
Monoclonal
Target
CD4
Add to Compare List
BioLegend
8999 BioLegend Way
San Diego
,
California
92121
United States
Phone
: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587
Company Profile
Website:
biolegend.com
Citations (92)
(1)
CD73 targeted combination therapy reverses PD-1 inhibitor resistance in CD73-high PD-L1-negative NSCLC: Evidence from pleural effusion organoids
Glob Med Genet
October 12, 2026
Zi-Rui Ren, Lv Wu, Qian-Lin Huang, Dong-Xuan Cai, Ying-Long Peng, Li-Bo Tang, Jia-Ting Li, Hong-Yi Zhu, Chong-Rui Xu, Chang Lu,
et al.
with an antibody cocktail (anti-human CD3-FITC
1:50
, Cat. No.
300306
; anti-human CD4-PE
1:50
, Cat. No.
300508
; anti-human CD8a-PE/Cyanine7
1:50
, Cat. No. 300914; anti-human CD137-APC
1:100
, Cat. No. 17–1379–42;
(2)
Engineering hematopoietic stem and progenitor cells to generate red blood cells as viral traps against HIV-1
Molecular Therapy Advances
September 10, 2026
Sofia E. Luna, William N. Feist, Kaya Ben-Efraim, Alex Pendergast, Freja K. Ekman, Britney Hernandez-Naughton, Megan Merritt-Garza, Kathleen Romero, Zak Kostamo, Nelson A. Amorin,
et al.
twice for purity. Cells were then stained with a CD4-PE (
clone
: RPA-T4,
BioLegend
, San Diego, CA, cat:
300508
) antibody and analyzed via
flow cytometry
for confirmation of CD4 expression. Allelic modification
(3)
Therapy induced senescence promotes immunogenicity in acute myeloid Leukemia through reduced EZH2 activity
Nat Commun
September 4, 2026
Diego Gilioli, Simona Fusco, Teresa Tavella, Tatiana Volpari, Antonella Santoro, Martin Schönlein, Kety Giannetti, Edoardo Carsana, Nicolò Gualandi, Roberta Noberini,
et al.
Biosciences), CD8 APC-Cy7 (cat#
344714
,
Biolegend
), CD4 FITC (cat#
980802
,
BioLegend
) or CD4 PE (cat#
300508
,
BioLegend
) when combined to
T-cells
degranulation
assay
,
CD69
APC (cat#
310910
, BioLegend),
CD25 PE
(4)
Optimization of B Cell Responses in Human Immune System Mice Through Organoid Based Screening
Advanced Science
June 26, 2026
Haiqiao Sun, He Li, Xu Zhu, Zijian Zhang, Deshan Ren, Shuai Ding, Yan Li
1/100), mCD45‐APC (
BioLegend
,
103112
, 1/100), CD3‐APC‐Cy7 (BioLegend, 300426, 1/100), CD4‐PE (
BioLegend
,
300508
, 1/100),
CD19
‐BUV395 (
BD Biosciences
, 363‐0459‐42, 1/100), CD19‐PE‐CF594 (
BD Biosciences
,
562294
, 1/100),
(5)
Targeting ATF4 overcomes dual resistance to chemo-immunotherapy in gastric cancer by disrupting the DNA damage response
J Immunother Cancer
June 8, 2026
Huili Ye, Wentao Zhang, Hongtai Cao, Zhiyi Peng, Tong Xu, Zhenhua Xia, Long Li, Na He, Yali Zhou, Junjie Qin,
et al.
anti-
human
antibodies:
FITC anti-human CD3
(#
317306
,
Biolegend
, RRID:AB_571907),
PE anti-human CD4
(#
300508
,
Biolegend
, RRID:AB_314075),
APC anti-human CD8
(#
344722
,
Biolegend
, RRID:AB_2075388), APC-Cy7 anti-human
(6)
Lyophilized mesenchymal stromal cell-derived extracellular vesicles for the oral treatment of inflammatory bowel disease: a novel cell-free therapeutic strategy
Stem Cell Research & Therapy
April 26, 2026
Shuangshuang Yang, Siyu Chen, Wenya Zhuang, Qiuhong Wang, Yi Xu, Taijie Zhan, Weifeng Huang, Yi Tan
(
302604
,
BioLegend
, San Diego, California, United States) and a PE-conjugated anti-human CD4 antibody (
300508
,
BioLegend
, San Diego, California, United States). Following
membrane
permeabilization,
staining
was
(7)
TBX20 regulates epithelial‑mesenchymal transition, maintains tumor stemness and immune factor expression, and promotes immune escape in lung cancer
Oncology Letters
March 30, 2026
Chuncai Xu, Peng Zhou, Yanting Zhang, Lili Li, Guowen Wang
anti-human CD3,
BioLegend, Inc
., cat. No.
317306
), CD4 (PE-anti-human CD4,
BioLegend, Inc
., Cat. No.
300508
). The labelled antibodies for CD8+ T cells are:
CD3
,
CD8
(PE anti-human CD8 Antibody,
BioLegend, Inc
.,
(8)
Overcoming claudin family homology: discovery of ARC101, a highly potent CLDN6-specific T-cell engager with a novel CD3 binder for ovarian adenocarcinoma
MAbs
March 10, 2026
Danlin Yang, Neha Kamran, Gururaj Shivange, Kavita Kumari, Prabhu Srinivas Yavvari, Viduth K. Chaugule, Vishal Mahajan, Bridget Larkin, Scott R. Brodeur, Joe Erhardt,
et al.
were resuspended in 100 µL of FACS buffer containing 2 µL each of
PE – anti-human CD4
(
BioLegend
, Cat#
300539
), AF647–anti-human CD8 (
BioLegend
, Cat#
344726
), and BV785–anti-human CD25 (
BioLegend
, Cat#
302638
).
(9)
TRBC2-targeting antibody–drug conjugates for the treatment of T cell cancers
Nature Cancer
December 22, 2025
Jiaxin Ge, Joshua Urban, Sarah R. DiNapoli, Bum Seok Lee, Taha Ahmedna, Tushar D. Nichakawade, Brian J. Mog, Steve Lu, Xuyang Li, Nikita Marcou,
et al.
OKT3,
BioLegend
, cat. no.
317318
), phycoerythrin (
PE) anti-human CD4
(
clone
RPA-T4,
BioLegend
, cat. no.
300508
), BV-421 anti-human CD3 (
clone
UCHT1,
BioLegend
, cat. no.
300434
), BV711 anti-human CD3 (
clone
OKT3,
(10)
Autologous Thymic Organoids Support Functional T-cell Education and Enhance Antitumor Immunity in Humanized Mice with Melanoma Xenografts
Cancer Research Communications
November 1, 2025
J. Jason Morton, Stephan A. Ramos, Nathaniel Alzofon, Stephen B. Keysar, Lucas H. Armitage, Alexander S. Baker, Jessie M. Barra, Tugs-Saikhan Chimed, Phuong N. Le, Cera Nieto,
et al.
CD3
, CD4, CD8,
PD-1
, HLA-DR (
BioLegend
, cat. #
300448
, RRID: AB_2563468; cat. #
300537
, RRID: AB_2562051/
300508
and RRID: AB_314076; cat. #
301050
, RRID: AB_2562055/
301049
and RRID: AB_2562054; cat. #
367422
, RRID:
(11)
Autologous Thymic Organoids Support Functional T-cell Education and Enhance Antitumor Immunity in Humanized Mice with Melanoma Xenografts
Cancer Res Commun
November 1, 2025
J. Jason Morton, Stephan A. Ramos, Nathaniel Alzofon, Stephen B. Keysar, Lucas H. Armitage, Alexander S. Baker, Jessie M. Barra, Tugs-Saikhan Chimed, Phuong N. Le, Cera Nieto,
et al.
CD3
, CD4, CD8,
PD-1
, HLA-DR (
BioLegend
, cat. #
300448
, RRID: AB_2563468; cat. #
300537
, RRID: AB_2562051/
300508
and RRID: AB_314076; cat. #
301050
, RRID: AB_2562055/
301049
and RRID: AB_2562054; cat. #
367422
, RRID:
(12)
HIV-1 manipulates CD96 on CD4 + T cells to subvert antiviral immunity
Science Advances
September 5, 2025
Sandra Dehn, Rabea Burkhard, Johanna Leyens, Tabea Kaiser, Simone Brandimarte, Dinah Heiligensetzer, Herwig Koppensteiner, Baubak Bajoghli, Stephan Hailfinger, Karin Schilbach,
et al.
μg/ml,
Miltenyi Biotec
,
130-129-977
PE anti-human CD4
,
Flow cytometry
,
1:50
in 1% FBS in PBS,
BioLegend
,
300508
PE anti-
human
CD317
,
Flow cytometry
,
1:50
in 1% FBS in PBS,
BioLegend
,
348406
"PE anti
human
HLA-ABC,",
Flow cytometry
(13)
Serum from patients with oral squamous cell carcinoma remodels the tumor immune escape ecological niche by promoting regulatory T‑cell differentiation and T‑cell exhaustion
Oncology Reports
August 26, 2025
Hongli Chen, Jiao Chen, Bomiao Cui, Die Lv, Wenwen Han, Yun Feng, Ping Zhang
with anti-human CD3-APC (cat. no. FC0003;
1:100
; Signalway Antibody LLC), anti-human CD4-PE (cat. no.
300508
;
1:100
;
BioLegend, Inc
.) or anti-CD8-PE (cat. no.
344705
;
1:100
;
BioLegend, Inc
.) antibodies at 4°C
(14)
CAR-T cell engineered with TCR-like antibody specific for HBV surface antigen epitope E183–91/HLA-A *0201 exhibit potent activity against HBV-HCC
Oncoimmunology
August 18, 2025
Fengling Wang, Jiaqian Li, Yong Huang, Feiyang Yan, Haozhan Gao, Weilin Zhou, Xinyu Gu, Dan Li, Yalan Zhang, Jing Li,
et al.
of CAR-
T cells
and MOCK-
T cells
. Anti-CD3-FITC (Biolegend, Cat:
300306
), anti-CD4-PE (
Biolegend
, Cat:
300508
), and anti-CD8α-APC (
Biolegend
, Cat:
300912
) antibody were used to characterize the subsets of CAR-
T cells
(15)
CAR-T cell engineered with TCR-like antibody specific for HBV surface antigen epitope E183-91/HLA-A *0201 exhibit potent activity against HBV-HCC
Oncoimmunology
August 18, 2025
Fengling Wang, Jiaqian Li, Yong Huang, Feiyang Yan, Haozhan Gao, Weilin Zhou, Xinyu Gu, Dan Li, Yalan Zhang, Jing Li,
et al.
of CAR-
T cells
and MOCK-
T cells
. Anti-CD3-FITC (Biolegend, Cat:
300306
), anti-CD4-PE (
Biolegend
, Cat:
300508
), and anti-CD8α-APC (
Biolegend
, Cat:
300912
) antibody were used to characterize the subsets of CAR-
T cells
(16)
Transmitted/founder (T/F) HIV-1 derived from sexual contact exhibits greater transmission fitness in human cervical tissue than T/F HIV-1 from blood-to-blood contact: Unique glycan profiles on T/F envelopes associated with transmission phenotypes
PLoS Pathog
May 23, 2025
Yiying Zhang, Katja Klein, Annette Ratcliff, Sashini Loku Galappaththi, Nicholas Hathaway, Nicholas Twells, Mukti Patel, Stephen Temesy, Jeffrey A. Bailey, Lara K. Mahal,
et al.
dissociation buffer (Cat #
13151014
,
Gibco
) and stained with PE-conjugated anti-human CD4 antibody (
300508
,
Biolegend
), APC-conjugated anti-
human
CCR5
antibody (
359122
,
Biolegend
) and Zombie
Violet
(
423113
,
(17)
Humanized mouse model reveals T cell ANXA2 as a potential therapeutic target in ischemic stroke
iScience
May 16, 2025
Tianyuan Zhang, Xiaojuan Zheng, Aijun Lu, Shuyuan Li, Keshen Li, Xiaoxiong Huang, Yanfang Liu, Wei Chen, Shengming Huang, Niu He,
et al.
AB_314394 anti-human CD3 -APC,
Biolegend
,Cat#
300312
; RRID: AB_314048 anti-human CD4-APC,
Biolegend
,Cat#
300508
; RRID: AB_314076 anti-human CD8-APC,
Biolegend
,Cat#
344709
; RRID: AB_2044009 anti-mouse CD3 -Alexa
(18)
Regulation of CXCR4 function by S1P1 through heteromerization
Cell Commun Signal
February 26, 2025
Hyun-Tae Kim, Jae-Yeon Jeong, Won-Ki Huh
purchased from
Invitrogen
. PerCP/Cyanine5.5 anti-human CD3 (UCHT1, #
300430
) and PE anti-human CD4 (RPA-T4, #
300508
) were purchased from
Biolegend
. TZ14011-AF488 was synthesized by AnyGen (Korea). Anti-
CXCR4
(Ulocuplumab)
(19)
Elevated BACE1 and IFNγ+ T Cells in Patients with Cognitive Impairment and the 5xFAD Mouse Model
ACS Chemical Neuroscience
February 5, 2025
Yaxi Zhan, Zuolong Chen, Shuxin Zheng, Linbin Dai, Wei Zhang, Yumeng Dai, Feng Gao, Yong Shen, Weiwei Zhang
at 4 °C for 30 min. The following antibodies were used:
CD3
-PerCP/Cy5.5 (
317336
,
Biolegend
), CD4-PE (
300508
,
Biolegend
), CD8-APC/Cy7 (
344713
,
Biolegend
), CCR7-FITC (
353216
,
Biolegend
), CD45RA-APC (
304112
,
Biolegend
),
(20)
Infiltrating lipid-rich macrophage subpopulations identified as a regulator of increasing prostate size in human benign prostatic hyperplasia
Front Immunol
January 10, 2025
Nadia Atallah Lanman, Era Meco, Philip Fitchev, Andree K. Kolliegbo, Meaghan M. Broman, Yana Filipovich, Harish Kothandaraman, Gregory M. Cresswell, Pooja Talaty, Malgorzata Antoniak,
et al.
CD3-APC [
clone
UCHT1] (
BioLegend
Cat#
300412
, RRID: AB_314066), CD4-PE [
clone
RPA-T4] (
BioLegend
Cat#
300508
, RRID: AB_314076), and
CD8
-BV510 [
clone
RPA-T8] (
BioLegend
Cat#
301048
, RRID: AB_2561942) antibodies.
Page
<<
<
1
2
3
4
5
>
>>
Reviews
Write a Review
(1)
1/12/2021
PE Anti-Human CD4 Clone RPA-T4 Works Great!
Anonymous Review
I was hoping to characterize the T cell population in a mixed PBMC sample. I used this antibody to identify the CD4+ T cells.
<<
<
>
>>
PE anti-human CD4 from BioLegend
Supplier Page
View Company Product Page
$325.00
Product Specs
Company Info
Citations
Reviews
Back To Top